. 2021 Jul 1;98(4):582–603. doi: 10.1111/cbdd.13913
© 2021 The Authors. Chemical Biology & Drug Design published by John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
FIGURE 1.
Structures of FPRs agonists